ImmuCell Corporation (ICCC) financials · rev $27.6M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
ImmuCell Corporation (ICCC) rev $27.6M.
| Line | FY2025 | FY2023 |
|---|---|---|
| Revenue | $27.6M | $17.5M |
| Cost of Revenue | $16.2M | $13.6M |
| Gross Profit | $11.4M | $3.87M |
| Operating Income | $1.65M | -$5.75M |
| Net Income | -$1.04M | -$5.77M |
| EPS (Diluted) | -$0.12 | -$0.75 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $42.5M | $45.1M |
| Current Assets | $16.9M | $15.0M |
| Cash & Equivalents | $3.81M | $3.76M |
| Inventory | $9.27M | $7.11M |
| PP&E | $21.1M | $25.3M |
| Total Liabilities | $15.5M | $17.6M |
| Current Liabilities | $3.98M | $4.41M |
| Short-term Debt | $1.61M | $1.50M |
| Long-term Debt | $7.49M | $9.04M |
| Total Debt | $9.10M† | $9.04M |
| Shareholders' Equity | $27.1M | $27.5M |
| Retained Earnings | -$15.2M | -$14.2M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $2.48M | $357.9K |
| CapEx | $1.25M | N/A |
| Investing Cash Flow | -$1.21M | -$461.2K |
| Financing Cash Flow | -$1.21M | $2.88M |
| Net Change in Cash | $48.6K | N/A |
| Free Cash Flow | $1.22M | N/A |
FAQ
What is ICCC P/E and revenue?
ImmuCell Corporation (ICCC) rev $27.6M.
What is ICCC revenue?
ImmuCell Corporation last cached revenue is $27.6M (FY2025).
Is ICCC profitable?
ImmuCell Corporation last cached net income is -$1.04M (FY2025).
What are ICCC total assets?
ImmuCell Corporation last cached total assets are $42.5M (FY2025).
What is ICCC free cash flow?
ImmuCell Corporation last cached free cash flow is $1.22M (FY2025).
Not investment advice. Cached statements, not a live tape.